Journal of Interventional Cardiology / 2023 / Article / Tab 4 / Research Article
In-Hospital and 1-Year Clinical Results from the French Registry Using Polymer-Free Sirolimus-Eluting Stents in Acute Coronary Syndrome and Stable Coronary Artery Disease Clinical outcomes Variable All patients Stable CAD ACS Number of patients 1456 895 561 — 205 STEMI Patients with follow-up 1340 (92.0%) 836 (93.4%) 504 (89.8%) 0.014 Time to follow-up or event in months 12.4 ± 0.7 12.4 ± 0.6 12.4 ± 0.9 0.142 In-hospital MACE 11 (0.8%) 4 (0.4%) 7 (1.2%) 0.086 In-hospital TLR 2 (0.1%) 1 (0.1%) 1 (0.2%) 0.739 Re-PCI 1 (0.1%) 1 (0.1%) 0 (0.0%) 0.428 CABG 1 (0.1%) 0 (0.0%) 1 (0.2%) 0.206 In-hospital MI 6 (0.4%) 1 (0.1%) 5 (0.9%) 0.024 In-hospital cardiac death 3 (0.2%) 2 (0.2%) 1 (0.2%) 0.853 12-month accumulated MACE 70 (5.2%) 33 (3.9%) 37 (7.3%) 0.007 Accumulated MACE interrupted DAPT 22 (3.9%) 9 (2.4%) 13 (7.2%) 0.073 Accumulated MACE no DAPT 48 (6.1%) 24 (5.2%) 24 (7.4%) Accumulated TLR 27 (2.0%) 16(1.9%) 11 (2.2%) 0.735 Re-PCI 25 (1.9%) 15 (1.8%) 10 (2.0%) 0.803 CABG 3 (0.2%) 1 (0.1%) 2 (0.4%) 0.298 Accumulated MI 15 (1.1%) 6 (0.7%) 9 (1.8%) 0.072 Accumulated all-cause death 33 (2.5%) 14 (1.7%) 19 (3.8%) 0.017 Accumulated stent thrombosis 8 (0.6%) 4 (0.5%) 4 (0.8%) 0.468 Accumulated bleeding complications postdischarge No bleeding 1280 (95.5%) 804 (96.2%) 476 (94.4%) 0.330 BARC 1–3 56 (4.2%) 30 (3.6%) 26 (5.2%) BARC >3 4 (0.3%) 2 (0.2%) 2 (0.4%)
